RETRACTED: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)

Armin Attar, Seyed Alireza Mirhosseini, Ahmad Monabati, Mohammad Kasaei, Firoozeh Abtahi, Yahya Kiwan, Massoud Vosough, Negar Azarpira

Open source

DOI: 10.1136/bmj-2024-083382
Published: 2025-10-29
Container: BMJ
Publisher: BMJ
Open access: unknown

Credibility signals

serious concern Score 5/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmj-2024-083382,
  title = {RETRACTED: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)},
  author = {Armin Attar and Seyed Alireza Mirhosseini and Ahmad Monabati and Mohammad Kasaei and Firoozeh Abtahi and Yahya Kiwan and Massoud Vosough and Negar Azarpira},
  year = {2025},
  journal = {BMJ},
  doi = {10.1136/bmj-2024-083382},
  url = {https://doi.org/10.1136/bmj-2024-083382}
}

RIS

TY  - JOUR
TI  - RETRACTED: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)
AU  - Armin Attar
AU  - Seyed Alireza Mirhosseini
AU  - Ahmad Monabati
AU  - Mohammad Kasaei
AU  - Firoozeh Abtahi
AU  - Yahya Kiwan
AU  - Massoud Vosough
AU  - Negar Azarpira
PY  - 2025
JO  - BMJ
DO  - 10.1136/bmj-2024-083382
UR  - https://doi.org/10.1136/bmj-2024-083382
ER  -

APA

Attar, A., Mirhosseini, S. A., Monabati, A., Kasaei, M., Abtahi, F., Kiwan, Y., Vosough, M., & Azarpira, N. (2025). RETRACTED: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8). BMJ. https://doi.org/10.1136/bmj-2024-083382

Source records

crossref · retrieved 2026-09-26T01:44:06.817Z